Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | +3.44% | +3.04% | +16.31% |
05-06 | VYNE Therapeutics Says US FDA Clears its Investigational New Drug Application for Potential Autoimmune Treatment | MT |
04-04 | Transcript : VYNE Therapeutics Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.31% | 38.21M | |
+31.52% | 690B | |
+24.54% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.49% | 235B | |
+4.25% | 199B | |
-10.43% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade